1. Peroxisome Proliferator-Activated Receptors in the Modulation of the Immune/Inflammatory Response in Atherosclerosis. (5th August 2008) Authors: Fernandez, Ana Z. Other Names: Gregoire Francine Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Peroxisome Proliferator-Activated Receptors in the Modulation of the Immune/Inflammatory Response in Atherosclerosis. (5th August 2008) Authors: Fernandez, Ana Z. Other Names: Gregoire Francine Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies. (16th July 2008) Authors: Deeg, Mark A.; Tan, Meng H. Other Names: Gregoire Francine Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies. (16th July 2008) Authors: Deeg, Mark A.; Tan, Meng H. Other Names: Gregoire Francine Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies. (21st August 2008) Authors: Deeg, Mark A.; Tan, Meng H. Other Names: Gregoire Francine Academic Editor. Journal: PPAR research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗